Publicación
Moderna stock jumped 130% following a successful human trial for its skin cancer vaccine. The treatment proved effective even for late-stage melanoma patients.
2w
102 Me gusta5 No me gusta10 Reposteos1 Comentarios
?
Moderna stock jumped 130% following a successful human trial for its skin cancer vaccine. The treatment proved effective even for late-stage melanoma patients.
2w
Moderna stock jumped 130% following a successful human trial for its skin cancer vaccine. The treatment proved effective even for late-stage melanoma patients.
2w
Aún no hay comentarios. ¡Sé el primero!
Comentarios
Aún no hay comentarios. ¡Sé el primero!